PMO Interview with the Innovator Series: Volume 4

Thomas C. Reynolds, MD, PhD
Video Categories: PMO Interview with the Innovator Series

Tom Reynolds, Chief Medical Officer of Seattle Genetics, offers a definition of personal medicine in this new video series from Personalized Medicine in Oncology.
March 31, 2015

Ibrutinib and ABT199 for CLL

Jennifer R. Brown, MD, PhD, at Dana-Farber Cancer Institute in Boston, discusses what she believes are the most important items coming out of ASH for CLL this year. She mentions excellent study results being presented about the drugs ibrutinib and ABT199.

September 2, 2015

Challenges with Oral Oncolytics for Payers and Practice Managers

Dixie-Lee Esseltine, MD and George Mulligan, PhD shed light on the challenges that payers and practice managers will face as more oncolytics come into the market.